The total return over the past 12 months is +32.59% vs. +16.94% for the S&P 500. So far it's up +86.90% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +32.59% | +20.77% | (40.61%) | (10.98%) | (5.68%) | (8.78%) |
| Total Return CAGR | +32.59% | +20.77% | (40.61%) | (10.98%) | (5.68%) | (8.78%) |
| Revenue CAGR | (61.64%) | (34.01%) | +118.86% | +36.02% | +36.10% | +23.32% |
| Net Income CAGR | (158.59%) | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | (158.24%) | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Novavax, Inc. (NVAX)
| Year | Start price | End price | NVAX Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $6.72 | $12.56 | +86.90% | +14.51% | +72.39% |
| 2025 | $8.04 | $6.72 | (16.42%) | +17.72% | (34.14%) |
| 2024 | $4.80 | $8.04 | +67.50% | +24.89% | +42.61% |
| 2023 | $10.28 | $4.80 | (53.31%) | +26.19% | (79.50%) |
| 2022 | $143.07 | $10.28 | (92.81%) | (18.17%) | (74.64%) |
| 2021 | $111.51 | $143.07 | +28.30% | +28.74% | (0.44%) |
| 2020 | $3.98 | $111.51 | +2701.76% | +18.37% | +2683.39% |
| 2019 | $36.80 | $3.98 | (89.18%) | +31.22% | (120.40%) |
| 2018 | $24.80 | $36.80 | +48.39% | (4.56%) | +52.95% |
| 2017 | $25.20 | $24.80 | (1.59%) | +21.70% | (23.29%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
